T. Mcdonald

发表

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin

B. Shields, A. Hattersley, B. Knight, 2012, BMC Endocrine Disorders.

Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype

A. Hattersley, S. Ellard, C. Acerini, 2012, Diabetologia.

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes

B. Shields, A. Hattersley, S. Ellard, 2011, Diabetes Care.

Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes

B. Shields, A. Hattersley, W. Hagopian, 2021, Diabetes Care.

Latent Autoimmune Diabetes of Adults ( LADA ) is likely to represent a mixed population of autoimmune ( type 1 ) and non-autoimmune ( type 2 ) diabetes

B. Shields, A. Hattersley, W. Hagopian, 2021 .

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

B. Shields, M. Weedon, A. Hattersley, 2019, Diabetologia.

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

Jimmy D Bell, M. McCarthy, T. Hansen, 2020, PLoS medicine.

Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes

J. Wason, E. Stevenson, R. Oram, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Measurement of Peak C-Peptide at Diagnosis Informs Glycemic Control but not Hypoglycemia in Adults With Type 1 Diabetes

R. Oram, T. Mcdonald, P. Narendran, 2021, Journal of the Endocrine Society.

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function

E. Stevenson, R. Oram, T. Mcdonald, 2020, Diabetes Care.

The Impact and Correction of Analysis Delay and Variability in Storage Temperature on the Assessment of HbA1c from Dried Blood Spots-an IMI DIRECT Study

M. Laakso, J. Dekker, F. Rutters, 2019 .

A cautionary tale: Unforeseen consequences of lean processing in a blood sciences laboratory.

T. Mcdonald, M. Perry, M. Salzmann, 2016, Clinical biochemistry.

The association between GAD65 antibody levels and incident Type 2 Diabetes Mellitus in an adult population: A meta-analysis.

F. Rutters, A. A. van der Heijden, J. Beulens, 2019, Metabolism: clinical and experimental.

Post-load glucose subgroups and associated metabolic traits in individuals with type 2 diabetes: An IMI-DIRECT study

M. McCarthy, T. Hansen, O. Pedersen, 2020, PloS one.

The association between postprandial urinary C‐peptide creatinine ratio and the treatment response to liraglutide: a multi‐centre observational study

A. Hattersley, A. Blann, S. Hunter, 2014, Diabetic medicine : a journal of the British Diabetic Association.

Strategies to identify individuals with monogenic diabetes: results of an economic evaluation

B. Shields, A. Hattersley, J. Peters, 2020, BMJ Open.

Tests aiding diagnosis of monogenic diabetes

T. Mcdonald, M. Shepherd, K. Colclough, 2017 .

Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes

B. Shields, A. Hattersley, S. Greene, 2016, Diabetes Care.

Stability of urinary albumin and creatinine after 12 months storage at −20 °C and −80 °C

A. Shore, T. Mcdonald, K. Gooding, 2019, Practical laboratory medicine.

Cystatin C is not a good candidate biomarker for HNF1A-MODY

A. Hattersley, K. Owen, J. Skupień, 2012, Acta Diabetologica.

Research: Treatment The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study

A. Hattersley, A. Blann, S. Hunter, 2013 .

Natalia NowakMagdalena SzopaGaya ThanabalasinghamTim J. McDonald • Kevin ColcloughJan SkupienTimothy J. JamesBeata Kiec-WilkElzbieta Kozek • Wojciech MlynarskiAndrew T. HattersleyKatharine R. OwenMaciej T. Malecki

A. Hattersley, K. Owen, J. Skupień, 2013 .

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy

B. Shields, M. Weedon, A. Hattersley, 2018, Diabetes Care.

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

B. Shields, A. Hattersley, B. Knight, 2015, Diabetes Care.

Markers of b-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

B. Shields, A. Hattersley, B. Knight, 2015 .

Pharmacogenomics of GLP-1 Receptor Agonists: A genome-wide analysis of observational data and large randomized controlled trials

M. Walker, A. Mahajan, L. T. ’t Hart, 2022, medRxiv.

Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study

Konstantinos D. Tsirigos, M. McCarthy, O. Pedersen, 2021, Diabetes.

C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase

B. Shields, A. Hattersley, N. Morgan, 2018, Diabetes Care.

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.

J. Barrett, M. Tremelling, M. Parkes, 2019, Gastroenterology.

Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?

T. Ahmad, N. Kennedy, C. Selinger, 2022, Alimentary Pharmacology and Therapeutics.

HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study

B. Shields, A. Hattersley, M. Nyirenda, 2021, BMJ Open Diabetes Research & Care.

Zinc transporter 8 autoantibody testing requires age-related cut-offs

T. Mcdonald, A. Jones, S. Grace, 2021, BMJ Open Diabetes Research & Care.

Type 1 Diabetes Patients With Different Residual Beta-Cell Function but Similar Age, HBA1c, and Cardiorespiratory Fitness Have Differing Exercise-Induced Angiogenic Cell Mobilisation

M. Campbell, T. Mcdonald, Jadine H. Scragg, 2022, Frontiers in Endocrinology.

Investigating hypokalaemia

R. Oram, T. Mcdonald, B. Vaidya, 2013, BMJ : British Medical Journal.

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.

B. Shields, A. Hattersley, S. Ellard, 2012, Clinica chimica acta; international journal of clinical chemistry.

Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?

B. Shields, A. Hattersley, T. Tree, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Urine C‐peptide creatinine ratio is an alternative to stimulated serum C‐peptide measurement in late‐onset, insulin‐treated diabetes

B. Shields, A. Hattersley, B. Knight, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Random non‐fasting C–peptide: bringing robust assessment of endogenous insulin secretion to the clinic

B. Shields, B. Knight, T. Mcdonald, 2016, Diabetic medicine : a journal of the British Diabetic Association.

The challenge of diagnosing type 1 diabetes in older adults

B. Shields, A. Hattersley, J. Dennis, 2020, Diabetic medicine : a journal of the British Diabetic Association.

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes

P. Bingley, A. Hattersley, F. Wong, 2016, Diabetologia.

Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide.

B. Shields, A. Hattersley, B. Knight, 2009, Clinical chemistry.

Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.

T. Mcdonald, M. Perry, 2016, Methods in molecular biology.

HbA1c measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care

B. Shields, T. Mcdonald, K. Young, 2021, medRxiv.

EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature

B. Shields, A. Hattersley, B. Knight, 2012, PloS one.

The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes

M. McCarthy, T. Hansen, O. Pedersen, 2020 .

Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes

A. Hattersley, R. Besser, T. Mcdonald, 2012, BMJ Case Reports.

High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes

B. Shields, A. Hattersley, S. Ellard, 2011, Diabetes Care.

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862

A. Hattersley, K. Owen, A. Gloyn, 2011, Diabetes Care.

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia

B. Shields, B. Knight, P. Choudhary, 2017, Diabetologia.

Comment on: “Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, −4 and −5 trials”

T. Mcdonald, A. Jones, 2018, Diabetes, obesity & metabolism.

Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues.

L. Couchman, T. Mcdonald, A. Armston, 2015, Clinical biochemistry.

University of Dundee Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes Koivula,

Jimmy D Bell, T. Hansen, O. Pedersen, 2014 .

The impact of gender on urine C-peptide creatinine ratio interpretation

B. Shields, A. Hattersley, B. Knight, 2012, Annals of clinical biochemistry.

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

C. Lees, T. Ahmad, L. Harries, 2022, Gut.

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

C. Lees, T. Ahmad, C. Lamb, 2021, Gut.

Proinsulin is stable at room temperature for 24 hours in EDTA: A clinical laboratory analysis (adAPT 3)

C. Sutherland, T. Mcdonald, M. Mostazir, 2017, PloS one.

Integration of biomarkers and clinical characteristics provides the best method for identifying patients with MODY

B. Shields, A. Hattersley, S. Ellard, 2012 .

Zinc Transporter 8 Autoantibodies (ZnT8A) and a Type 1 Diabetes Genetic Risk Score Can Exclude Individuals With Type 1 Diabetes From Inappropriate Genetic Testing for Monogenic Diabetes

B. Shields, M. Weedon, A. Hattersley, 2018, Diabetes Care.

A high‐sensitivity electrochemiluminescence‐based ELISA for the measurement of the oxidative stress biomarker, 3‐nitrotyrosine, in human blood serum and cells

A. Pitt, J. Littlechild, M. Isupov, 2018, Free radical biology & medicine.

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study

Thomas M. Riley, C. Lees, T. Ahmad, 2022, Alimentary pharmacology & therapeutics.

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Susan M. Kilroy, C. Lees, T. Ahmad, 2022, Nature Communications.

The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project

S. Brunak, F. De Masi, Ramneek Gupta, 2018, Life Sciences, Society and Policy.

Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England

R. Byford, F. Walter, T. Mcdonald, 2021, British Journal of Cancer.

Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive

B. Knight, T. Mcdonald, B. Vaidya, 2017, Clinical medicine.

Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic

B. Shields, A. Hattersley, S. Ellard, 2018, Clinical kidney journal.

Validating the positivity thresholds of drug‐tolerant anti‐infliximab and anti‐adalimumab antibody assays

T. Ahmad, N. Kennedy, T. Mcdonald, 2020, Alimentary pharmacology & therapeutics.

Interleukin-1 antagonism in type 1 diabetes of long duration.

K. Timper, M. Donath, R. Oram, 2016, Diabetes & metabolism.

Covid-19 vaccine-induced antibodies are attenuated and decay rapidly in infliximab treated patients

C. Lees, T. Ahmad, James C. Lee, 2021 .

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Sarah F. Griffee, Susan M. Kilroy, Philip Smith, 2022, The Lancet Gastroenterology & Hepatology.

Home Urine C-Peptide Creatinine Ratio Can Be Used to Monitor Islet Transplant Function

M. Rutter, A. Hattersley, K. Burling, 2014, Diabetes Care.

Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients

B. Shields, A. Hattersley, S. Ellard, 2017, Diabetes Care.

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

B. Shields, A. Hattersley, S. Ellard, 2012, Diabetologia.

Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes

P. Bingley, B. Shields, A. Hattersley, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes

B. Shields, A. Hattersley, B. Knight, 2011, Diabetes Care.

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

B. Shields, A. Hattersley, B. Knight, 2013, Diabetologia.

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Ulrik Plesner Jacobsen, M. McCarthy, O. Pedersen, 2023, Nature Biotechnology.

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

C. Lees, T. Ahmad, D. McGovern, 2021, Gut.

Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study

M. McCarthy, O. Pedersen, S. Brunak, 2020, Genome medicine.

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.

M. Parkes, C. Lees, J. Mansfield, 2019, The lancet. Gastroenterology & hepatology.

Maturity onset diabetes of the young: identification and diagnosis

S. Ellard, T. Mcdonald, 2013, Annals of clinical biochemistry.

Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis

B. Shields, A. Hattersley, N. Morgan, 2020, Diabetologia.

Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study

T. Ahmad, R. Russell, N. Kennedy, 2020, Archives of Disease in Childhood.

The phenotype of type 1 diabetes in sub-Saharan Africa

E. Sobngwi, T. Mcdonald, J. Katte, 2023, Frontiers in Public Health.

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

B. Shields, M. Weedon, A. Hattersley, 2015, Diabetes Care.

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients

C. Lees, T. Ahmad, James C. Lee, 2021, medRxiv.

Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study

Konstantinos D. Tsirigos, Jimmy D Bell, M. McCarthy, 2020, EBioMedicine.

Genetic analysis of blood molecular phenotypes reveals regulatory networks affecting complex traits: a DIRECT study.

M. McCarthy, C. Howald, T. Hansen, 2021, medRxiv.

Infliximab and adalimumab are stable in whole blood clotted samples for seven days at room temperature

Tariq Ahmad, T. Mcdonald, M. Perry, 2015, Annals of clinical biochemistry.

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium

Jimmy D Bell, M. McCarthy, T. Hansen, 2019, Diabetologia.

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium

Jimmy D Bell, T. Hansen, O. Pedersen, 2014, Diabetologia.

The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project

S. Brunak, F. De Masi, Ramneek Gupta, 2018, Life sciences, society and policy.

Clinical profiles of post‐load glucose subgroups and their association with glycaemic traits over time: An IMI‐DIRECT study

M. Ridderstråle, M. Laakso, M. Walker, 2020, Diabetic medicine : a journal of the British Diabetic Association.

A reference map of potential determinants for the human serum metabolome

M. McCarthy, M. Arumugam, O. Pedersen, 2020, Nature.

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease

J. Kere, A. Hattersley, Å. Lernmark, 2014, Nature Genetics.

The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype

B. Shields, M. Weedon, A. Hattersley, 2013, Journal of Medical Genetics.

Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics

B. Shields, N. Oliver, D. Johnston, 2021, medRxiv.

Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With KCNJ11-Related Neonatal Diabetes

F. Ashcroft, A. Hattersley, C. Mathieu, 2014, Diabetes Care.

A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes

A. Hattersley, S. Ellard, K. Patel, 2018, Diabetologia.

HLA-DQA1*05 is associated with the development of antibodies to anti-TNF therapy

J. Barrett, M. Parkes, C. Lees, 2018, bioRxiv.

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

Philip Smith, C. Lees, N. Kennedy, 2021, Journal of Crohn's & colitis.

Method Comparison Between ELISAs Suggests Therapeutic Ranges for Infliximab Should Be Assay-Specific.

T. Mcdonald, M. Perry, 2018, The journal of applied laboratory medicine.

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.

M. Jani, T. Mcdonald, M. Hoyle, 2021, Health technology assessment.

Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis

S. Logan, M. Jani, J. Peters, 2019 .

Validation of a single‐sample urinary C‐peptide creatinine ratio as a reproducible alternative to serum C‐peptide in patients with Type 2 diabetes

B. Shields, B. Knight, T. Mcdonald, 2012, Diabetic medicine : a journal of the British Diabetic Association.

Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

M. McCarthy, T. Hansen, O. Pedersen, 2022, Cell reports. Medicine.

Home urine C‐peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes

B. Shields, A. Hattersley, T. Barrett, 2012, Pediatric diabetes.

Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study

S. Heller, M. Evans, L. Leelarathna, 2019, Diabetes Care.

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

A. Hattersley, D. Feig, H. Murphy, 2021, Diabetes Care.

Investigating hyperkalaemia in adults

R. Oram, T. Mcdonald, B. Vaidya, 2015, BMJ : British Medical Journal.

Diagnostic performance of the faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: a service evaluation in the South West of England

F. Walter, T. Mcdonald, G. Abel, 2020, medRxiv.

Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells

A. Hattersley, W. Hagopian, S. Ellard, 2020, Diabetologia.

Predicting and elucidating the etiology of fatty liver disease using a machine learning-based approach: an IMI DIRECT study

Jimmy D Bell, M. McCarthy, T. Hansen, 2020 .

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

B. Shields, M. Weedon, A. Hattersley, 2018, Diabetes Care.

A novel case of a raised testosterone and LH in a young man.

T. Mcdonald, M. Perry, M. Salzmann, 2011, Clinica chimica acta; international journal of clinical chemistry.

Low IgE Is a Useful Tool to Identify STAT3 Gain-of-Function Mutations.

A. Hattersley, S. Flanagan, T. Mcdonald, 2016, Clinical chemistry.

Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease.

T. Ahmad, N. Kennedy, T. Mcdonald, 2021, Journal of Crohn's & colitis.

Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors

B. Shields, A. Hattersley, R. Oram, 2014, Diabetes Care.

Processes Underlying Glycemic Deterioration in Type 2 Diabetes

Konstantinos D. Tsirigos, Jimmy D Bell, O. Pedersen, 2020 .

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes

P. McKeigue, S. Rich, J. Chalmers, 2019, BMC Medicine.

3. A Novel, Inexpensive Test Can Discriminate between Type 1 and Type 2 Diabetes (1745-P)

M. Weedon, A. Hattersley, K. Patel, 2015, Nederlands Tijdschrift voor Diabetologie.

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study

B. Shields, A. Hattersley, J. Dennis, 2021, BMC Medicine.

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years

B. Shields, M. Weedon, A. Hattersley, 2019, BMJ Open.

University of Dundee Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 1850 years

B. Shields, M. Weedon, A. Hattersley, 2019 .

Parental experiences of a diagnosis of neonatal diabetes and perceptions of newborn screening for glucose: a qualitative study

B. Knight, T. Mcdonald, M. Shepherd, 2020, BMJ Open.

Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement

A. Hattersley, S. Ellard, B. Knight, 2017, Diabetologia.

Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of <5 years in the Iranian population

S. Ellard, H. Yaghootkar, K. Patel, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study

B. Shields, A. Hattersley, B. Knight, 2013, BMJ Open.

Urinary C‐peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes

B. Shields, A. Hattersley, R. Besser, 2013, Diabetic medicine : a journal of the British Diabetic Association.

The HNF 4 A R 76 W

B. Shields, M. Weedon, A. Hattersley, 2014 .

Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study

Konstantinos D. Tsirigos, Jimmy D Bell, M. McCarthy, 2020, Diabetes Care.

Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-KATP-channel pathways

B. Shields, A. Hattersley, B. Knight, 2019, BMJ Open Diabetes Research & Care.

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: an overview of the data from the epidemiological studies within the IMI DIRECT Consortium

Jimmy D Bell, M. McCarthy, T. Hansen, 2018, bioRxiv.

Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

Konstantinos D. Tsirigos, M. McCarthy, C. Howald, 2023, Nature communications.

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

B. Shields, M. Weedon, A. Hattersley, 2019, Diabetologia.

Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study

T. Ahmad, N. Kennedy, G. Heap, 2018, Alimentary pharmacology & therapeutics.

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

P. McKeigue, C. Palmer, J. Chalmers, 2020, Diabetes Care.

Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease

T. Ahmad, N. Kennedy, T. Mcdonald, 2023, Crohn's & colitis 360.

The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

Jimmy D Bell, O. Pedersen, S. Brunak, 2020, Diabetologia.

Inferring causal pathways between metabolic processes and liver fat accumulation: an IMI DIRECT study

Konstantinos D. Tsirigos, Jimmy D Bell, M. Ridderstråle, 2021, medRxiv.

A novel case of a raised testosterone and LH in a young man.

T. Mcdonald, M. Perry, M. Salzmann, 2011, Clinica chimica acta; international journal of clinical chemistry.

Effect of the Holiday Season in Patients With Diabetes: Glycemia and Lipids Increase Postholiday, but the Effect Is Small and Transient

B. Shields, A. Hattersley, T. Mcdonald, 2014, Diabetes Care.

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes

J. Holst, B. Shields, A. Hattersley, 2023, Journal of diabetes investigation.